# ADHD PreSMA Response Inhibition Therapy

> **NCT06325813** · NA · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 40 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DEVICE:** Active repetitive TMS
- **DEVICE:** Sham repetitive TMS

## Key facts

- **NCT ID:** NCT06325813
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-03
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325813, "ADHD PreSMA Response Inhibition Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06325813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
